35 filings
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
30 May 24
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
6 May 24
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
4:04pm
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
20 Mar 24
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
4:05pm
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
5 Feb 24
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of
8:10am
8-K
RANI
Rani Therapeutics Holdings Inc - Ordinary Shares
19 Dec 23
Departure of Directors or Certain Officers
4:06pm
8-K
n0ck50gxur3yxitkwwvo
14 Dec 23
Other Events
8:05am
8-K
334qq4
8 Nov 23
Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
4:10pm
8-K
h3h9y
1 Nov 23
Entry into a Material Definitive Agreement
4:04pm
8-K
xkvry4o51 lr
25 Oct 23
Other Events
8:03am
8-K
35qpwqgcr4
7 Sep 23
Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies
5:04pm
8-K
sc1gvcgihqih63nw
11 Aug 23
Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
4:05pm
8-K
s15hf cgu3wk6v0e
5 Jun 23
Entry into a Material Definitive Agreement
8:00am
8-K
eamnuim5z4h nf
30 May 23
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
y2x9mt0 5dnm
10 May 23
Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update
4:16pm
8-K
8zz 1smjlnq01dxw7
5 Apr 23
Other Events
4:10pm
8-K
vzf8 2r1l
22 Mar 23
Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update
4:04pm
8-K
8g2z hm47dh3poiownni
9 Jan 23
Entry into a Material Definitive Agreement
8:09am
8-K
3xjeaufx4nw
5 Jan 23
Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update
4:19pm
8-K
qu2b wu2f
30 Dec 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
11:57am
8-K
1j0t4z ew
6 Dec 22
Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study
4:05pm